Samenza 40mg Capsule
  1. Home
  2. Pharma Products
  3. Samarth Life Sciences Pvt Ltd
  4. Samenza 40mg Capsule

Samenza 40mg Capsule

Samenza 40 mg Capsule contains enzalutamide 40 mg, an oral androgen receptor inhibitor used in the treatment of prostate cancer. It works by blocking androgen signaling that can support the growth of prostate cancer cells. The capsule can be taken with or without food according to the prescribed treatment regimen.

BUY NOW

Category

Enzalutamide inhibits androgen receptor signaling at multiple stages, helping limit hormone-driven prostate cancer cell growth. Samenza is used in specific treatment settings for advanced prostate cancer, including disease that has spread or remains responsive to androgen-deprivation treatment. The 40 mg capsule is supplied in a pack of 28 capsules and is marketed by Samarth Life Sciences Pvt Ltd. It should be stored below 30°C and taken consistently according to the oncologist’s instructions.

Technical Specification

Specification Details
Active Ingredient Enzalutamide
Strength 40 mg
Dosage Form Capsule
Route of Administration Oral
Pack Size 28 capsules
Marketer Samarth Life Sciences Pvt Ltd

Product Also Known As

Samenza 40 mg Capsule, Samenza 40 Capsule, Samenza 40 mg, Samenza Enzalutamide Capsule, Enzalutamide 40 mg Capsule, Enzalutamide 40 mg, Enzalutamide Prostate Cancer Capsule